Clinical studies revealed that increased P-gp expression in CKD characterized by high plasma levels of IS may result in increased hepatic metabolism of cyclosporine (P-gp substrate) (Santana Machado et al., 2018). This evidence concerns the gene PGP and chronic kidney disease.